InvestorsObserver is giving Kala Pharmaceuticals Inc (KALA) an Analyst Rating Rank of 27, meaning KALA is ranked higher by analysts than 27% of stocks. The average price target for KALA is $4.458 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating KALA a Buy today. Find out what this means to you and get the rest of the rankings on KALA!